Goldman Sachs’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Sell |
|
|||||
|
2025
Q1 | $233K | Sell |
|
|||||
|
2024
Q4 | $950K | Buy |
|
|||||
|
2024
Q3 | $468K | Buy |
|
|||||
|
2024
Q2 | $1.3M | Buy |
|
|||||
|
2024
Q1 | $1.75M | Buy |
|
|||||
|
2023
Q4 | $1.35M | Sell |
|
|||||
|
2023
Q3 | $629K | Sell |
|
|||||
|
2023
Q2 | $1.35M | Sell |
|
|||||
|
2023
Q1 | $817K | Buy |
|
|||||
|
2022
Q4 | $1.98M | Buy |
|
|||||
|
2022
Q3 | $1.54M | Sell |
|
|||||
|
2022
Q2 | $2M | Buy |
|
|||||
|
2022
Q1 | $3.63M | Buy |
|
|||||
|
2021
Q4 | $2.99M | Sell |
|
|||||
|
2021
Q3 | $12M | Buy |
|
|||||
|
2021
Q2 | $7.46M | Sell |
|
|||||
|
2021
Q1 | $18.7M | Buy |
|
|||||
|
2020
Q4 | $11.3M | Buy |
|
|||||
|
2020
Q3 | $279K | Buy |
|